Allosteric Activation of α7 Nicotinic Acetylcholine Receptors by Novel 2-Arylamino-thiazole-5-carboxylic Acid Amide Derivatives for the Improvement of Cognitive Deficits in Mice

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Preclinical study demonstrates rescue of auditory gating deficits in mice, highlighting a novel therapeutic approach for cognitive disorders.

Novel positive allosteric modulators activate human alpha7 nicotinic acetylcholine receptors, reversing auditory gating deficits in a mouse schizophrenia model.
The lead compound achieves an EC50 of 1.3 μM and produces a 48-fold current amplification in oocytes during co-application with acetylcholine.
Highlights potential therapies for cognitive deficits using prepulse inhibition restoration—mouse model; further preclinical work needed before clinical translation.

Yang et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark

Preclinical study demonstrates rescue of auditory gating deficits in mice, highlighting a novel therapeutic approach for cognitive disorders.